BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17096334)

  • 21. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
    Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
    Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I.
    Chu LW; Zhu Y; Yu K; Zheng T; Chokkalingam AP; Stanczyk FZ; Gao YT; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3268-73. PubMed ID: 18990770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A direct repeat of E-box-like elements is required for cell-autonomous circadian rhythm of clock genes.
    Nakahata Y; Yoshida M; Takano A; Soma H; Yamamoto T; Yasuda A; Nakatsu T; Takumi T
    BMC Mol Biol; 2008 Jan; 9():1. PubMed ID: 18177499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral circadian oscillators require CLOCK.
    DeBruyne JP; Weaver DR; Reppert SM
    Curr Biol; 2007 Jul; 17(14):R538-9. PubMed ID: 17637349
    [No Abstract]   [Full Text] [Related]  

  • 25. Postnatal ontogenesis of molecular clock in mouse striatum.
    Cai Y; Liu S; Li N; Xu S; Zhang Y; Chan P
    Brain Res; 2009 Apr; 1264():33-8. PubMed ID: 19171124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circadian variation of blood pressure and the vascular response to asynchronous stress.
    Curtis AM; Cheng Y; Kapoor S; Reilly D; Price TS; Fitzgerald GA
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3450-5. PubMed ID: 17360665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing NPAS2 promotes cell growth and invasion in DLD-1 cells and correlated with poor prognosis of colorectal cancer.
    Xue X; Liu F; Han Y; Li P; Yuan B; Wang X; Chen Y; Kuang Y; Zhi Q; Zhao H
    Biochem Biophys Res Commun; 2014 Jul; 450(2):1058-62. PubMed ID: 24978311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
    Gu F; Zhang H; Hyland PL; Berndt S; Gapstur SM; Wheeler W; Ellipse Consortium T; Amos CI; Bezieau S; Bickeböller H; Brenner H; Brennan P; Chang-Claude J; Conti DV; Doherty JA; Gruber SB; Harrison TA; Hayes RB; Hoffmeister M; Houlston RS; Hung RJ; Jenkins MA; Kraft P; Lawrenson K; McKay J; Markt S; Mucci L; Phelan CM; Qu C; Risch A; Rossing MA; Wichmann HE; Shi J; Schernhammer E; Yu K; Landi MT; Caporaso NE
    Int J Cancer; 2017 Nov; 141(9):1794-1802. PubMed ID: 28699174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock.
    DeBruyne JP; Weaver DR; Reppert SM
    Nat Neurosci; 2007 May; 10(5):543-5. PubMed ID: 17417633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual role of the CLOCK/BMAL1 circadian complex in transcriptional regulation.
    Kondratov RV; Shamanna RK; Kondratova AA; Gorbacheva VY; Antoch MP
    FASEB J; 2006 Mar; 20(3):530-2. PubMed ID: 16507766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectroscopic and DNA-binding characterization of the isolated heme-bound basic helix-loop-helix-PAS-A domain of neuronal PAS protein 2 (NPAS2), a transcription activator protein associated with circadian rhythms.
    Mukaiyama Y; Uchida T; Sato E; Sasaki A; Sato Y; Igarashi J; Kurokawa H; Sagami I; Kitagawa T; Shimizu T
    FEBS J; 2006 Jun; 273(11):2528-39. PubMed ID: 16704425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hylan G-F 20 attenuates posttraumatic osteoarthritis progression: Association with upregulated expression of the circardian gene NPAS2.
    Liu CC; Su LJ; Tsai WY; Sun HL; Lee HC; Wong CS
    Life Sci; 2015 Nov; 141():20-4. PubMed ID: 26388558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt.
    Farawela H; Khorshied M; Shaheen I; Gouda H; Nasef A; Abulata N; Mahmoud HA; Zawam HM; Mousa SM
    Infect Genet Evol; 2012 Aug; 12(6):1189-94. PubMed ID: 22522002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women.
    Zhang Y; Holford TR; Leaderer B; Boyle P; Zahm SH; Zhang B; Zou K; Morton LM; Owens PH; Flynn S; Tallini G; Zheng T
    Am J Epidemiol; 2004 Oct; 160(8):766-73. PubMed ID: 15466499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurobiology. Despite mutated gene, mouse circadian clock keeps on ticking.
    Miller G
    Science; 2006 May; 312(5774):673. PubMed ID: 16675672
    [No Abstract]   [Full Text] [Related]  

  • 37. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.
    Wang SS; Davis S; Cerhan JR; Hartge P; Severson RK; Cozen W; Lan Q; Welch R; Chanock SJ; Rothman N
    Carcinogenesis; 2006 Sep; 27(9):1828-34. PubMed ID: 16543247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circadian genes and risk of prostate cancer: Findings from the EPICAP study.
    Wendeu-Foyet MG; Koudou Y; Cénée S; Trétarre B; Rébillard X; Cancel-Tassin G; Cussenot O; Boland A; Bacq D; Deleuze JF; Lamy PJ; Mulot C; Laurent-Puig P; Truong T; Menegaux F
    Int J Cancer; 2019 Oct; 145(7):1745-1753. PubMed ID: 30665264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm.
    Shi J; Wittke-Thompson JK; Badner JA; Hattori E; Potash JB; Willour VL; McMahon FJ; Gershon ES; Liu C
    Am J Med Genet B Neuropsychiatr Genet; 2008 Oct; 147B(7):1047-55. PubMed ID: 18228528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell Non-Hodgkin Lymphoma in Egypt.
    Rahman HA; Khorshied MM; Khorshid OM; Mahgoub SM
    Ann Hematol; 2014 Nov; 93(11):1859-65. PubMed ID: 24912772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.